LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 932

Search options

  1. Article ; Online: A novel mitochondrial DNA m.7507A>G mutation is only pathogenic at high levels of heteroplasmy.

    McCann, Beverly Jo / Tuppen, Helen A L / Küsters, Benno / Lammens, Martin / Smeitink, Jan A M / Taylor, Robert W / Rodenburg, Richard J / Wortmann, Saskia B

    Neuromuscular disorders : NMD

    2014  Volume 25, Issue 3, Page(s) 262–267

    Abstract: ... gene, m.7507A>G. The index patient died during the neonatal period due to cardio-respiratory failure ... of the m.7507A>G mutation in several tissues and a severe reduction in the steady-state level of mt ... that the m.7507A>G mutation causes a heterogeneous clinical phenotype and is only pathogenic at very high ...

    Abstract We present a Dutch family with a novel disease-causing mutation in the mitochondrial tRNA(Ser(UCN)) gene, m.7507A>G. The index patient died during the neonatal period due to cardio-respiratory failure and fatal lactic acidosis. A second patient, his cousin, has severe hearing loss necessitating cochlear implants and progressive exercise intolerance. Laboratory investigations of both patients revealed combined deficiencies of the enzyme complexes of the mitochondrial respiratory chain in several tissues. Reduced levels of fully assembled complexes I and IV in fibroblasts by BN-PAGE associated with (near) homoplasmic levels of the m.7507A>G mutation in several tissues and a severe reduction in the steady-state level of mt-tRNA(Ser(UCN)) in fibroblasts were observed. The novel mitochondrial DNA mutation was shown to segregate with disease; several healthy maternal family members showed high heteroplasmy levels (up to 76 ± 4% in blood and 68 ± 4% in fibroblasts) which did not lead to any alterations in the activities of the enzyme complexes of the respiratory chain in fibroblasts or clinical signs and symptoms. We hereby conclude that the m.7507A>G mutation causes a heterogeneous clinical phenotype and is only pathogenic at very high levels of mtDNA heteroplasmy.
    MeSH term(s) Acidosis, Lactic/genetics ; Acidosis, Lactic/pathology ; Acidosis, Lactic/physiopathology ; Adult ; Cells, Cultured ; Child, Preschool ; DNA, Mitochondrial ; Family ; Fatal Outcome ; Female ; Fibroblasts/physiology ; Hearing Loss/genetics ; Hearing Loss/pathology ; Hearing Loss/physiopathology ; Heart Failure/genetics ; Heart Failure/pathology ; Heart Failure/physiopathology ; Humans ; Infant, Newborn ; Male ; Middle Aged ; Mutation ; Pedigree ; RNA, Transfer, Ser/genetics ; Respiratory Insufficiency/genetics ; Respiratory Insufficiency/pathology ; Respiratory Insufficiency/physiopathology
    Chemical Substances DNA, Mitochondrial ; RNA, Transfer, Ser
    Language English
    Publishing date 2014-11-13
    Publishing country England
    Document type Case Reports ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1077681-3
    ISSN 1873-2364 ; 0960-8966
    ISSN (online) 1873-2364
    ISSN 0960-8966
    DOI 10.1016/j.nmd.2014.11.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: INNO-LiPA DNA line probe assay misidentification of M. smegmatis as Mycobacterium fortuitum complex.

    van den Broek, Theo / Janssen, Nard G / Hetem, David J / Bekers, Wouter / Kamst, Miranda / Fluit, Ad C / van Ingen, Jakko / Kusters, Johannes G / Rentenaar, Rob J

    Diagnostic microbiology and infectious disease

    2019  Volume 95, Issue 3, Page(s) 114858

    Abstract: Seven weeks after being kicked in the face by a cow, a 34-year-old male patient developed a posttraumatic mycobacterial lymphadenitis. A rapidly growing mycobacterial isolate cultured from a surgically drained lymphadenitis pus specimen was identified as ...

    Abstract Seven weeks after being kicked in the face by a cow, a 34-year-old male patient developed a posttraumatic mycobacterial lymphadenitis. A rapidly growing mycobacterial isolate cultured from a surgically drained lymphadenitis pus specimen was identified as Mycobacterium smegmatis by matrix-assisted laser desorption/ionization mass spectrometry and a combination of ITS-, hsp65-, and 16S rRNA-DNA sequence analysis, but as Mycobacterium fortuitum complex using the commercial INNO-LiPA Mycobacteria v2 line probe assay. As it is unclear if the misidentification of this strain is an exception, more research is required.
    MeSH term(s) Adult ; Animals ; Cattle ; Diagnostic Errors ; Humans ; Lymphadenitis/diagnosis ; Lymphadenitis/microbiology ; Lymphadenitis/pathology ; Lymphadenitis/therapy ; Male ; Microbial Sensitivity Tests ; Molecular Diagnostic Techniques/methods ; Molecular Diagnostic Techniques/standards ; Mycobacterium Infections, Nontuberculous/diagnosis ; Mycobacterium Infections, Nontuberculous/microbiology ; Mycobacterium Infections, Nontuberculous/pathology ; Mycobacterium Infections, Nontuberculous/surgery ; Mycobacterium fortuitum/chemistry ; Mycobacterium fortuitum/classification ; Mycobacterium fortuitum/genetics ; Mycobacterium smegmatis/chemistry ; Mycobacterium smegmatis/classification ; Mycobacterium smegmatis/genetics ; Reagent Kits, Diagnostic ; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization ; Treatment Outcome
    Chemical Substances Reagent Kits, Diagnostic
    Language English
    Publishing date 2019-06-24
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 604920-5
    ISSN 1879-0070 ; 0732-8893
    ISSN (online) 1879-0070
    ISSN 0732-8893
    DOI 10.1016/j.diagmicrobio.2019.06.010
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Reply to Francesco Montorsi, Simone Scuderi, Alberto Briganti, and Giorgio Gandaglia's Letter to the Editor re: Melline G.M. Schilham, Mark Rijpkema, Tom Scheenen, et al. How Advanced Imaging Will Guide Therapeutic Strategies for Patients with Newly Diagnosed Prostate Cancer in the Years to Come. Eur Urol 2022;82:578-80.

    Schilham, Melline G M / Rijpkema, Mark / Scheenen, Tom / Hermsen, Rick / Barentsz, Jelle O / Sedelaar, J P Michiel / Kusters-Vandevelde, Heidi / Kerkmeijer, Linda G W / Somford, Diederik M / Gotthardt, Martin

    European urology

    2023  Volume 83, Issue 5, Page(s) e133–e134

    MeSH term(s) Male ; Humans ; Prostatic Neoplasms/surgery ; Prostatectomy ; Patients
    Language English
    Publishing date 2023-02-11
    Publishing country Switzerland
    Document type Letter ; Comment
    ZDB-ID 193790-x
    ISSN 1873-7560 ; 1421-993X ; 0302-2838
    ISSN (online) 1873-7560 ; 1421-993X
    ISSN 0302-2838
    DOI 10.1016/j.eururo.2023.01.023
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Book ; Online: Hot issues on the M&E agenda

    Guijt, I.M. / Kusters, C.S.L. / Lont, H. / Visser, I.

    2012  

    Abstract: This report summarises the discussions and presentations of the Expert Seminar ‘Hot Issues on the M ... international cooperation. The report describes the hot issues on the M&E agenda, divided into a global top 10 of hot issues ...

    Abstract This report summarises the discussions and presentations of the Expert Seminar ‘Hot Issues on the M&E Agenda’, which took place in Wageningen on March 23, 2012. The Expert Seminar was organised by the Wageningen UR Centre for Development Innovation in collaboration with Learning by Design and Context, international cooperation. The report describes the hot issues on the M&E agenda, divided into a global top 10 of hot issues, the politics of evaluation, the battle field of rigour, and the future of evaluative practice.
    Keywords Life Science
    Language English
    Publisher Centre for Development Innovation
    Publishing country nl
    Document type Book ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  5. Article: Food Fraud - (K)ein Thema für die Bundeswehr?

    Küsters, M.

    Wehrmedizin und Wehrpharmazie

    2021  Volume 45, Issue 1, Page(s) 22

    Language German
    Document type Article
    ZDB-ID 506117-9
    ISSN 0043-2148
    Database Current Contents Medicine

    More links

    Kategorien

  6. Article ; Online: Current and emerging monoclonal antibodies for treating familial hypercholesterolemia in children.

    Reijman, M Doortje / Kusters, D Meeike / Wiegman, Albert

    Expert opinion on biological therapy

    2024  Volume 24, Issue 4, Page(s) 243–249

    Abstract: Introduction: Heterozygous familial hypercholesterolemia (HeFH) is a common genetic disorder caused by pathogenic variants in the LDL-C metabolism. Lifelong exposure to elevated LDL-C levels leads to a high risk of premature cardiovascular disease. To ... ...

    Abstract Introduction: Heterozygous familial hypercholesterolemia (HeFH) is a common genetic disorder caused by pathogenic variants in the LDL-C metabolism. Lifelong exposure to elevated LDL-C levels leads to a high risk of premature cardiovascular disease. To reduce that risk, children with HeFH should be identified and treated with lipid-lowering therapy. The cornerstone consists of statins and ezetimibe, but not in all patients this lowers the LDL-C levels to treatment targets. For these patients, more intensive lipid-lowering therapy is needed.
    Areas covered: In this review, we provide an overview of the monoclonal antibodies which are currently available or being tested for treating HeFH in childhood.
    Expert opinion: Monoclonal antibodies that inhibit PCSK9 are first in line lipid-lowering treatment options if oral statin and ezetimibe therapy are insufficient, due to intolerance or very high baseline LDL-C levels. Both evolocumab and alirocumab have been shown to be safe and effective in children with HeFH. For children, evolocumab has been registered from the age of 10 years old and alirocumab from the age of 8 years old. The costs of these new agents are much higher than oral therapy, which makes it important to only use them in a selected patient population.
    MeSH term(s) Humans ; Hyperlipoproteinemia Type II/drug therapy ; Hyperlipoproteinemia Type II/immunology ; Antibodies, Monoclonal/therapeutic use ; Antibodies, Monoclonal/adverse effects ; Child ; Anticholesteremic Agents/therapeutic use ; Anticholesteremic Agents/adverse effects ; Antibodies, Monoclonal, Humanized/therapeutic use ; Antibodies, Monoclonal, Humanized/adverse effects ; Cholesterol, LDL/blood ; PCSK9 Inhibitors ; Proprotein Convertase 9
    Chemical Substances Antibodies, Monoclonal ; Anticholesteremic Agents ; Antibodies, Monoclonal, Humanized ; alirocumab (PP0SHH6V16) ; Cholesterol, LDL ; evolocumab (LKC0U3A8NJ) ; PCSK9 protein, human (EC 3.4.21.-) ; PCSK9 Inhibitors ; Proprotein Convertase 9 (EC 3.4.21.-)
    Language English
    Publishing date 2024-03-21
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2052501-1
    ISSN 1744-7682 ; 1471-2598
    ISSN (online) 1744-7682
    ISSN 1471-2598
    DOI 10.1080/14712598.2024.2330948
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Book ; Online: Revisiting the Alpha Algorithm To Enable Real-Life Process Discovery Applications -- Extended Report

    Küsters, Aaron / van der Aalst, Wil M. P.

    2023  

    Abstract: The Alpha algorithm was the first process discovery algorithm that was able to discover process models with concurrency based on incomplete event data while still providing formal guarantees. However, as was stated in the original paper, practical ... ...

    Abstract The Alpha algorithm was the first process discovery algorithm that was able to discover process models with concurrency based on incomplete event data while still providing formal guarantees. However, as was stated in the original paper, practical applicability is limited when dealing with exceptional behavior and processes that cannot be described as a structured workflow net without short loops. This paper presents the Alpha+++ algorithm that overcomes many of these limitations, making the algorithm competitive with more recent process mining approaches. The different steps provide insights into the practical challenges of learning process models with concurrency, choices, sequences, loops, and skipping from event data. The approach was implemented in ProM and tested on various publicly available, real-life event logs.

    Comment: 55 pages, 97 figures
    Keywords Computer Science - Databases
    Publishing date 2023-05-28
    Publishing country us
    Document type Book ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  8. Article ; Online: Preferential ordering of incommensurate-length guest particles in a smectic host.

    Kusters, Guido L A / Barella, Martijn / van der Schoot, Paul

    The Journal of chemical physics

    2024  Volume 160, Issue 8

    Abstract: ... previously hypothesized to result from temporary caging effects [M. Chiappini, E. Grelet, and M. Dijkstra ...

    Abstract Using density functional theory, we study the preferential ordering of rod-like guest particles immersed in a smectic host fluid. Within a model of perfectly aligned rods and assuming that the guest particles do not perturb the smectic host fluid, simple excluded-volume arguments explain that guest particles that are comparable in length to the host particles order in phase with the smectic host density layering, whereas guest particles that are considerably shorter or longer order in antiphase. The corresponding free-energy minima are separated by energetic barriers on the order of the thermal energy kBT, suggesting that guest particles undergo hopping-type diffusion between adjacent smectic layers. Upon introducing a slight orientational mismatch between the guest particles and the perfectly aligned smectic host, an additional, smaller free-energy barrier emerges for a range of intermediate guest-to-host length ratios, which splits the free-energy minimum into two. Guest particles in this range occupy positions intermediate between in-phase ordering and in-antiphase ordering. Finally, we use Kramers' theory to identify slow, fast, and intermediate diffusive regimes for the guest particles as a function of their length. Our model is in qualitative agreement with experiment and simulation and provides an alternative, complementary explanation in terms of a free-energy landscape for the intermediate diffusive regime, which was previously hypothesized to result from temporary caging effects [M. Chiappini, E. Grelet, and M. Dijkstra, Phys. Rev. Lett. 124, 087801 (2020)]. We argue that our simple model of aligned rods captures the salient features of incommensurate-length guest particles in a smectic host if a slight orientational mismatch is introduced.
    Language English
    Publishing date 2024-02-26
    Publishing country United States
    Document type Journal Article
    ZDB-ID 3113-6
    ISSN 1089-7690 ; 0021-9606
    ISSN (online) 1089-7690
    ISSN 0021-9606
    DOI 10.1063/5.0190802
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Identification of the domain which determines the g,m serotype of the flagellin of Salmonella enteritidis.

    van Asten, A J / Zwaagstra, K A / Baay, M F / Kusters, J G / Huis in't Veld, J H / van der Zeijst, B A

    Journal of bacteriology

    1995  Volume 177, Issue 6, Page(s) 1610–1613

    Abstract: ... screened with a g,m-specific monoclonal antibody. Results showed that the g,m epitope is localized between ...

    Abstract Clones expressing fragments of the flagellin protein of Salmonella enteritidis were constructed and screened with a g,m-specific monoclonal antibody. Results showed that the g,m epitope is localized between amino acids 258 and 348 of the flagellin. The fliC gene, encoding the flagellin of S. enteritidis, was proven to be the only flagellin gene present in S. enteritidis.
    MeSH term(s) Amino Acid Sequence ; Antigens, Bacterial/genetics ; Antigens, Bacterial/immunology ; Base Sequence ; Cloning, Molecular ; Epitope Mapping ; Epitopes/genetics ; Epitopes/immunology ; Flagellin/genetics ; Flagellin/immunology ; Molecular Sequence Data ; Peptide Fragments/genetics ; Peptide Fragments/immunology ; Salmonella enteritidis/genetics ; Salmonella enteritidis/immunology ; Sequence Homology, Amino Acid ; Serotyping
    Chemical Substances Antigens, Bacterial ; Epitopes ; Peptide Fragments ; Flagellin (12777-81-0)
    Language English
    Publishing date 1995-03
    Publishing country United States
    Document type Comparative Study ; Journal Article
    ZDB-ID 2968-3
    ISSN 1098-5530 ; 0021-9193
    ISSN (online) 1098-5530
    ISSN 0021-9193
    DOI 10.1128/jb.177.6.1610-1613.1995
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Lipid metabolism during pregnancy: consequences for mother and child.

    Mulder, Janneke W C M / Kusters, D Meeike / Roeters van Lennep, Jeanine E / Hutten, Barbara A

    Current opinion in lipidology

    2024  Volume 35, Issue 3, Page(s) 133–140

    Abstract: Purpose of review: Accommodating fetal growth and development, women undergo multiple physiological changes during pregnancy. In recent years, several studies contributed to the accumulating evidence about the impact of gestational hyperlipidemia on ... ...

    Abstract Purpose of review: Accommodating fetal growth and development, women undergo multiple physiological changes during pregnancy. In recent years, several studies contributed to the accumulating evidence about the impact of gestational hyperlipidemia on cardiovascular risk for mother and child. This review aims to provide a comprehensive overview of the current research on lipid profile alterations during pregnancy and its associated (cardiovascular) outcomes for mother and child from a clinical perspective.
    Recent findings: In a normal pregnancy, total and LDL-cholesterol levels increase by approximately 30-50%, HDL-cholesterol by 20-40%, and triglycerides by 50-100%. In some women, for example, with familial hypercholesterolemia (FH), a more atherogenic lipid profile is observed. Dyslipidemia during pregnancy is found to be associated with adverse (cardiovascular) outcomes for the mother (e.g. preeclampsia, gestational diabetes, metabolic syndrome, unfavorable lipid profile) and for the child (e.g. preterm birth, large for gestational age, preatherosclerotic lesions, unfavorable lipid profile).
    Summary: The lipid profile of women during pregnancy provides a unique window of opportunity into the potential future cardiovascular risk for mother and child. Better knowledge about adverse outcomes and specific risk groups could lead to better risk assessment and earlier cardiovascular prevention. Future research should investigate implementation of gestational screening possibilities.
    MeSH term(s) Humans ; Pregnancy ; Female ; Lipid Metabolism ; Cardiovascular Diseases/metabolism ; Cardiovascular Diseases/blood ; Pregnancy Complications/metabolism ; Pregnancy Complications/blood ; Child ; Lipids/blood
    Chemical Substances Lipids
    Language English
    Publishing date 2024-02-21
    Publishing country England
    Document type Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 1045394-5
    ISSN 1473-6535 ; 0957-9672
    ISSN (online) 1473-6535
    ISSN 0957-9672
    DOI 10.1097/MOL.0000000000000927
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top